- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about OCDX
Recent news which mentions OCDX
Tickers
OCDX
From Motley Fool
Why Quidel Was Trouncing the Market on Tuesday
February 22, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2022
February 17, 2022
From Benzinga
Tickers
OCDX
From Motley Fool
Earnings Scheduled For February 16, 2022
February 16, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 04, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 03, 2022
From Benzinga
Hedge Against the Omicron Variant by Buying These 2 Stocks
December 29, 2021
From Motley Fool
10 Biggest Price Target Changes For Monday
December 27, 2021
From Benzinga
CROX Stock: The $2.5B HEYDUDE Deal That Has Crocs Investors Crying Today
December 23, 2021
From InvestorPlace
OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher
December 23, 2021
From InvestorPlace
Tesla Leads Automobile Stocks to be Among Wednesday's Top Performers
December 23, 2021
From Benzinga
From Motley Fool
Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights
December 23, 2021
From Benzinga
Tickers
OCDX
From Motley Fool
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
48 Biggest Movers From Yesterday
September 10, 2021
From Benzinga
Tickers
OCDX
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.